These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 11303791)

  • 1. p14ARF deletion and methylation in genetic pathways to glioblastomas.
    Nakamura M; Watanabe T; Klangby U; Asker C; Wiman K; Yonekawa Y; Kleihues P; Ohgaki H
    Brain Pathol; 2001 Apr; 11(2):159-68. PubMed ID: 11303791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas.
    Watanabe T; Nakamura M; Yonekawa Y; Kleihues P; Ohgaki H
    Acta Neuropathol; 2001 Mar; 101(3):185-9. PubMed ID: 11307615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas.
    Newcomb EW; Alonso M; Sung T; Miller DC
    Hum Pathol; 2000 Jan; 31(1):115-9. PubMed ID: 10665922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL; Ueki K; Jhung SL; Koh J; Louis DN
    J Neuropathol Exp Neurol; 1998 Feb; 57(2):122-30. PubMed ID: 9600204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas.
    Nishimine M; Nakamura M; Kishi M; Okamoto M; Shimada K; Ishida E; Kirita T; Konishi N
    Oncol Rep; 2003; 10(3):555-60. PubMed ID: 12684623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis].
    Tang SH; Yang DH; Luo HS; Yu JP; Shu JC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.
    Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
    Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS
    Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma.
    Ohta S; Uemura H; Matsui Y; Ishiguro H; Fujinami K; Kondo K; Miyamoto H; Yazawa T; Danenberg K; Danenberg PV; Tohnai I; Kubota Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):81-91. PubMed ID: 19101490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
    Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
    Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
    Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
    Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer.
    Chang LL; Yeh WT; Yang SY; Wu WJ; Huang CH
    J Urol; 2003 Aug; 170(2 Pt 1):595-600. PubMed ID: 12853838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
    Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
    Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.
    Lee M; Sup Han W; Kyoung Kim O; Hee Sung S; Sun Cho M; Lee SN; Koo H
    Pathol Res Pract; 2006; 202(6):415-24. PubMed ID: 16675157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
    Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F
    J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemizygous or homozygous deletion of the chromosomal region containing the p16INK4a gene is associated with amplification of the EGF receptor gene in glioblastomas.
    Hegi ME; zur Hausen A; Rüedi D; Malin G; Kleihues P
    Int J Cancer; 1997 Sep; 73(1):57-63. PubMed ID: 9334810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype.
    Chapman EJ; Harnden P; Chambers P; Johnston C; Knowles MA
    Clin Cancer Res; 2005 Aug; 11(16):5740-7. PubMed ID: 16115911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.